Cliff Asness's STIM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 116,680 shares of Neuronetics, Inc. (STIM) worth $169,187, representing 0.00% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in STIM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 116,680 shares. Largest reduction occurred in Q1 2022, reducing 51,152 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Neuronetics (STIM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neuronetics (STIM) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +116,680 | New Buy | 116,680 | $1.45 |
| Q1 2022 | -51,152 | Sold Out | 0 | $0.00 |
| Q4 2021 | +30,160 | Add 143.67% | 51,152 | $4.46 |
| Q3 2021 | +5,276 | Add 33.57% | 20,992 | $6.57 |
| Q2 2021 | +15,716 | New Buy | 15,716 | $16.03 |
Cliff Asness's Neuronetics Investment FAQs
Cliff Asness first purchased Neuronetics, Inc. (STIM) in Q2 2021, acquiring 15,716 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Neuronetics, Inc. (STIM) for 5 quarters since Q2 2021.
Cliff Asness's largest addition to Neuronetics, Inc. (STIM) was in Q1 2026, adding 116,680 shares worth $169,187.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 116,680 shares of Neuronetics, Inc. (STIM), valued at approximately $169,187.
As of the Q1 2026 filing, Neuronetics, Inc. (STIM) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Neuronetics, Inc. (STIM) was 116,680 shares, as reported at the end of Q1 2026.